Who owns REVANCE THERAPEUTICS INC?
- CUSIP Number: 761330ab5
Tip: Access positions for across all investors
Analyze quarterly positions in Revance Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Revance Therapeutics stock
Who bought or sold REVANCE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 44M | $34M | 0% | Dec 2023 |
|
| D. E. Shaw & Co | 38M | $29M | 0% | Dec 2023 |
|
| Graham Capital Management | 32M | $24M | 0% | Dec 2023 |
|
| Context Capital Management | 31M | $24B | 171164% | Dec 2023 |
|
| Aviva | 22M | $17M | -8% | Dec 2023 |
|
| Highbridge Capital Management | 20M | $14B | -5% | Dec 2023 |
|
| SSI Investment Management | 7.8M | $6.0M | 14% | Dec 2023 |
|
| Calamos Advisors | 4.0M | $3.0M | 0% | Dec 2023 |
|
| Amundi | 3.4M | $2.5M | 0% | Dec 2023 |
|
| Credit Suisse | 2.0M | $1.8M | 0% | Dec 2023 |
|
| CSS | 1.7M | $1.3M | -71% | Dec 2023 |
|
| Citigroup | 500k | $380k | 0% | Dec 2023 |
|
| First Hawaiian Bank | 190k | $138k | 73% | Mar 2024 |
|
| William Blair $ Company | 25k | $19k | 0% | Dec 2023 |
|
| Barclays | 19k | $14k | -99% | Dec 2023 |
|
Who sold out of Revance Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Capstone Investment Advisors | Sep 2023 | 7.5M | $6.1M |
| Readystate Asset Management | Sep 2023 | 5.0M | $4.0M |
| Wolverine Asset Management | Sep 2023 | 2.1M | $1.6M |
| Bank Of Montreal | Sep 2023 | 1.5M | $1.8M |
| Bank of New York Mellon | Sep 2023 | 200k | $162k |